{"url_path":"/sec/mdt/10-k/2026/item-13","section_key":"item-13","section_title":"Item 13 Certain Relationships and Related Transactions, and Director Independence","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-18","source_url":"https://www.sec.gov/Archives/edgar/data/1613103/0001628280-26-044354-index.html","accession_number":"0001628280-26-044354","cik":"0001613103","ticker":"MDT","issuer_name":"Medtronic plc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1613103/0001628280-26-044354-index.html","primary_entity_key":"0001613103","primary_entity_name":"Medtronic plc"},"word_count":70,"has_tables":true,"body_markdown":"Item 13. Certain Relationships and Related Transactions, and Director Independence\n\nThe information required by Item 13 will be included in our Proxy Statement for the 2026 Annual General Meeting of Shareholders under the headings “Corporate Governance — Director Independence” and “Corporate Governance — Related Party Transactions and Other Matters,” and is incorporated herein by reference. The Proxy Statement will be filed no later than 120 days after April 24, 2026."}